FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372497003: Selegiline (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197790010 Selegiline (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211032012 Selegiline en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1822681000195113 selegilina it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
839671000172114 sélégiline fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Selegiline (substance) Is a Antiparkinsonian agent (substance) true Inferred relationship Some
Selegiline (substance) Is a Monoamine oxidase B inhibitor true Inferred relationship Some
Selegiline (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Monoamine oxidase B inhibitor (disposition) true Inferred relationship Some
Selegiline (substance) Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Selegiline (substance) Is a Monoamine oxidase inhibitor false Inferred relationship Some
Selegiline (substance) Is a allergène médicamenteux false Inferred relationship Some
Selegiline (substance) Is a Amine true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Selegiline hydrochloride Is a False Selegiline (substance) Inferred relationship Some
Product containing selegiline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Selegiline (substance) Inferred relationship Some 1
Selegiline measurement Component True Selegiline (substance) Inferred relationship Some 1
Selegiline poisoning Causative agent (attribute) True Selegiline (substance) Inferred relationship Some 1
Accidental selegiline poisoning Causative agent (attribute) False Selegiline (substance) Inferred relationship Some
Intentional selegiline poisoning Causative agent (attribute) False Selegiline (substance) Inferred relationship Some
intoxication par la sélégiline d'intention indéterminée Causative agent (attribute) False Selegiline (substance) Inferred relationship Some 1
Selegiline adverse reaction Causative agent (attribute) True Selegiline (substance) Inferred relationship Some 1
Allergy to selegiline (finding) Causative agent (attribute) False Selegiline (substance) Inferred relationship Some
Selegiline overdose Causative agent (attribute) True Selegiline (substance) Inferred relationship Some 1
Accidental selegiline overdose Causative agent (attribute) True Selegiline (substance) Inferred relationship Some 1
Intentional selegiline overdose (disorder) Causative agent (attribute) True Selegiline (substance) Inferred relationship Some 1
surdose de sélégiline d'intention indéterminée Causative agent (attribute) False Selegiline (substance) Inferred relationship Some 1
Accidental selegiline poisoning Causative agent (attribute) True Selegiline (substance) Inferred relationship Some 1
Intentional selegiline poisoning Causative agent (attribute) True Selegiline (substance) Inferred relationship Some 1
Selegiline 6mg/24hours transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Selegiline (substance) Inferred relationship Some
Selegiline 9mg/24hours transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Selegiline (substance) Inferred relationship Some
Selegiline 12mg/24hours transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Selegiline (substance) Inferred relationship Some
Allergy to selegiline (finding) Causative agent (attribute) True Selegiline (substance) Inferred relationship Some 1
Selegiline hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Selegiline (substance) Inferred relationship Some
Product containing selegiline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Selegiline (substance) Inferred relationship Some 1
Selegiline-containing product in transdermal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Selegiline (substance) Inferred relationship Some 1
Selegiline only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Selegiline (substance) Inferred relationship Some 1
Product containing only selegiline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Selegiline (substance) Inferred relationship Some 1
Selegiline only product in transdermal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Selegiline (substance) Inferred relationship Some 1
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Selegiline (substance) Inferred relationship Some 1
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Selegiline (substance) Inferred relationship Some 1
Selegiline 500 microgram/hour prolonged-release transdermal patch This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Selegiline (substance) Inferred relationship Some 1
Selegiline 500 microgram/hour prolonged-release transdermal patch The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Selegiline (substance) Inferred relationship Some 1
Selegiline 375 microgram/hour prolonged-release transdermal patch The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Selegiline (substance) Inferred relationship Some 1
Selegiline 375 microgram/hour prolonged-release transdermal patch This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Selegiline (substance) Inferred relationship Some 1
Selegiline-containing product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Selegiline (substance) Inferred relationship Some 1
Selegiline only product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Selegiline (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start